These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8420760)

  • 21. Euglycaemic hyperinsulinaemia does not affect gastric emptying in type I and type II diabetes mellitus.
    Kong MF; King P; Macdonald IA; Blackshaw PE; Horowitz M; Perkins AC; Armstrong E; Buchanan KD; Tattersall RB
    Diabetologia; 1999 Mar; 42(3):365-72. PubMed ID: 10096791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects.
    Meier JJ; Kemmeries G; Holst JJ; Nauck MA
    Diabetes; 2005 Jul; 54(7):2212-8. PubMed ID: 15983224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Protein Preload Enhances the Glucose-Lowering Efficacy of Vildagliptin in Type 2 Diabetes.
    Wu T; Little TJ; Bound MJ; Borg M; Zhang X; Deacon CF; Horowitz M; Jones KL; Rayner CK
    Diabetes Care; 2016 Apr; 39(4):511-7. PubMed ID: 26786576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid gastric emptying of a solid pancake meal in type II diabetic patients.
    Schwartz JG; Green GM; Guan D; McMahan CA; Phillips WT
    Diabetes Care; 1996 May; 19(5):468-71. PubMed ID: 8732711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release.
    Enç FY; Imeryüz N; Akin L; Turoğlu T; Dede F; Haklar G; Tekeşin N; Bekiroğlu N; Yeğen BC; Rehfeld JF; Holst JJ; Ulusoy NB
    Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G752-63. PubMed ID: 11518688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between gastric emptying and an alpha-glucosidase inhibitor effect on postprandial hyperglycemia in NIDDM patients.
    Kawagishi T; Nishizawa Y; Taniwaki H; Tanaka S; Okuno Y; Inaba M; Ishimura E; Emoto M; Morii H
    Diabetes Care; 1997 Oct; 20(10):1529-32. PubMed ID: 9314629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastric inhibitory polypeptide in obesity and diabetes mellitus.
    Service FJ; Rizza RA; Westland RE; Hall LD; Gerich JE; Go VL
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1133-40. PubMed ID: 6373812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of accelerated gastric emptying of liquids and hyperglycemia in patients with type II diabetes mellitus.
    Frank JW; Saslow SB; Camilleri M; Thomforde GM; Dinneen S; Rizza RA
    Gastroenterology; 1995 Sep; 109(3):755-65. PubMed ID: 7657103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperglycemia acutely lowers the postprandial excursions of glucagon-like Peptide-1 and gastric inhibitory polypeptide in humans.
    Vollmer K; Gardiwal H; Menge BA; Goetze O; Deacon CF; Schmidt WE; Holst JJ; Meier JJ
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1379-85. PubMed ID: 19174495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A role for pancreatic polypeptide in the regulation of gastric emptying and short-term metabolic control.
    Schmidt PT; Näslund E; Grybäck P; Jacobsson H; Holst JJ; Hilsted L; Hellström PM
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5241-6. PubMed ID: 15998783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of lipase inhibition on gastric emptying of, and on the glycaemic, insulin and cardiovascular responses to, a high-fat/carbohydrate meal in type 2 diabetes.
    O'Donovan D; Horowitz M; Russo A; Feinle-Bisset C; Murolo N; Gentilcore D; Wishart JM; Morris HA; Jones KL
    Diabetologia; 2004 Dec; 47(12):2208-14. PubMed ID: 15662558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: relationships with postprandial glycemic and insulinemic responses.
    Little TJ; Pilichiewicz AN; Russo A; Phillips L; Jones KL; Nauck MA; Wishart J; Horowitz M; Feinle-Bisset C
    J Clin Endocrinol Metab; 2006 May; 91(5):1916-23. PubMed ID: 16492694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes.
    Meier JJ; Gallwitz B; Salmen S; Goetze O; Holst JJ; Schmidt WE; Nauck MA
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2719-25. PubMed ID: 12788879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM.
    Kong MF; King P; Macdonald IA; Stubbs TA; Perkins AC; Blackshaw PE; Moyses C; Tattersall RB
    Diabetologia; 1997 Jan; 40(1):82-8. PubMed ID: 9028722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of exogenous glucagon-like peptide-1 on gastric emptying and glucose absorption in the critically ill: relationship to glycemia.
    Deane AM; Chapman MJ; Fraser RJ; Summers MJ; Zaknic AV; Storey JP; Jones KL; Rayner CK; Horowitz M
    Crit Care Med; 2010 May; 38(5):1261-9. PubMed ID: 20228679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of cholecystokinin-octapeptide (CCK-8) on food intake and gastric emptying in man.
    Muurahainen N; Kissileff HR; Derogatis AJ; Pi-Sunyer FX
    Physiol Behav; 1988; 44(4-5):645-9. PubMed ID: 3237850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decelerating gastric emptying: therapeutic possibilities in type 2 diabetes.
    Phillips WT; Schwartz JG
    Diabet Med; 1996 Sep; 13(9 Suppl 5):S44-8. PubMed ID: 8894471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of gastric emptying in humans by cholecystokinin.
    Liddle RA; Morita ET; Conrad CK; Williams JA
    J Clin Invest; 1986 Mar; 77(3):992-6. PubMed ID: 3949984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects.
    Chaikomin R; Doran S; Jones KL; Feinle-Bisset C; O'Donovan D; Rayner CK; Horowitz M
    Am J Physiol Endocrinol Metab; 2005 Sep; 289(3):E504-7. PubMed ID: 15886226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of gender on the acute effects of whey protein ingestion on energy intake, appetite, gastric emptying and gut hormone responses in healthy young adults.
    Giezenaar C; Luscombe-Marsh ND; Hutchison AT; Lange K; Hausken T; Jones KL; Horowitz M; Chapman I; Soenen S
    Nutr Diabetes; 2018 Jul; 8(1):40. PubMed ID: 30006513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.